| 查看: 400 | 回复: 2 | |||
| 本帖产生 1 个 翻译EPI ,点击这里进行查看 | |||
[求助]
求大侠翻译
|
|||
|
Indeed, ferrocene derivatives have been proposed as antianemics, and one such compound, ferrocerone, was clinically approved in the USSR. To the best of our knowledge, this compoundwas the firstmarketed transition organometal drug. In this context, it is worth mentioning that another ferrocene-containing compound, which is a close derivative of chloroquine, has successfully passed clinical phase II trials as an antimalarial drug candidate The idea of using ruthenium-containing organometallics as anticancer agents was first developed by Tochter et al. [ Last edited by LFJ0319 on 2012-5-28 at 22:49 ] |
» 收录本帖的淘帖专辑推荐
精品翻译集锦 |
» 本帖已获得的红花(最新10朵)
» 猜你喜欢
导师想让我从独立一作变成了共一第一
已经有9人回复
博士读完未来一定会好吗
已经有23人回复
到新单位后,换了新的研究方向,没有团队,持续积累2区以上论文,能申请到面上吗
已经有11人回复
读博
已经有4人回复
JMPT 期刊投稿流程
已经有4人回复
心脉受损
已经有5人回复
Springer期刊投稿求助
已经有4人回复
小论文投稿
已经有3人回复
申请2026年博士
已经有6人回复
8814402
至尊木虫 (职业作家)
- 翻译EPI: 509
- 应助: 18 (小学生)
- 贵宾: 0.381
- 金币: 12916.1
- 散金: 47
- 红花: 16
- 帖子: 4183
- 在线: 357.8小时
- 虫号: 1184404
- 注册: 2011-01-06
- 专业: 药物学其他科学问题
【答案】应助回帖
★ ★ ★ ★ ★ ★
sltmac: 金币+1 2012-05-31 08:51:15
sltmac: 金币+5, 翻译EPI+1 2012-06-20 09:28:49
sltmac: 金币+1 2012-05-31 08:51:15
sltmac: 金币+5, 翻译EPI+1 2012-06-20 09:28:49
| Indeed, ferrocene derivatives have been proposed as antianemics, and one such compound, ferrocerone, was clinically approved in the USSR. 确实,二茂铁衍生物已被推荐为抗贫血药,其中一个化合物已在USSR获得临床许可。To the best of our knowledge, this compoundwas the firstmarketed transition organometal drug. 就我们所知,此化合物是第一个市场化的有机金属药物。In this context, it is worth mentioning that another ferrocene-containing compound, which is a close derivative of chloroquine, has successfully passed clinical phase II trials as an antimalarial drug candidate在这种背景下,值得一提的是,另一个含二茂铁的化合物,是氯喹的亲缘衍生物,已经成功地通过了抗疟候选药物二期临床。The idea of using ruthenium-containing organometallics as anticancer agents was first developed by Tochter et al.采用含钌有机金属化合物为抗肿瘤药物的思想最早由Tochter等提出。 |
2楼2012-05-29 08:26:01
3楼2012-05-29 10:25:57













回复此楼
LFJ0319
thank!